4574 Taiko Pharmaceutical
- 392
- -7-1.75%
Taiko Pharmaceutical News
List of stocks with cloud breakout (weekly) [Ichimoku Kinko Hyo, List of stocks with cloud breakouts]
List of stocks that broke through the clouds: Market Code Company Name Close Leading Span A Leading Span B Tokyo Stock Exchange Prime Board 1301 GYOKUYO CO., LTD. 3830 3791.25 3730 2206 EZAKI GLICO CO., LTD. 4205 4163.75 3910 2211 FUJIYA CO., LTD. 2525 2466 2493 2269 MEIJI HOLDINGS CO., LTD.
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1433＞ Vestella 951 977 ＜1773＞ YTL 127 149 ＜2148＞ ITM 1813 1892 ＜2307＞ Crosscat 1322 1451 ＜2317＞ Cystena
Brands that moved the day before part 1 TOWA, Meiko, ASICS, etc.
<コード>Stock name closing price on the 13th ⇒ Toray ＜3402＞ 781.8 +62.425/3 business profit is expected to increase 31.6% compared to the previous day. San-in Joint Bank ＜8381＞ 1488 +231 announced a stock buyback with an upper limit of 1.74% of the number of issued shares. Transcity ＜9310＞ 901 +150 announced a stock buyback with an upper limit of 2.52% of the number of issued shares. ASJ ＜2351＞ 559 +5024 earnings forecasts for the fiscal year ending March 31 were revised upward. Trust HD ＜3286＞ 635 +100 shares
Front market [stocks that have moved, stocks that have been created]
*MEC ＜4971＞ 4550 - Earnings forecasts were revised upward due to a significant increase in profit for the first quarter. *Miyakoshi HD ＜6620＞ 1375 Ka - View the project discussion progress release as material. *Noritz Steel ＜7744＞ 3860 cars - Earnings forecasts were drastically revised upward due to a significant increase in profit for the first quarter. *ASICS ＜7936＞ 8750 cars - Earnings for the first quarter increased profit significantly exceeded consensus. *Nissin ＜9066＞ 4495 - Announcement of drastic dividend increases and implementation of high-level stock buybacks
Turnover change rate ranking (around 9 o'clock) ~ Tokyo Keiki, Imperial Hotel, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [5/13 9:35 as of 9:35] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜157A＞ G Monster 226200 107185.08 266.16% 0.127
Taiko Pharmaceutical: Confirmation
Taiko Pharmaceutical: Quarterly Report - 79th Term 1st Quarter (2024/01/01 - 2024/03/31)
Taiko Pharmaceutical Sees FY Net Y550.00M
Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2024 Revenue Y6.80 bln Operating Profit Y410.00 mln Pre
Taiko Pharmaceutical: Consolidated Financial Results Report for the 1st Quarter of the Fiscal Year Ending 2024/12 (FY2024)
Taiko Pharmaceutical: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending 2024/12 [Japanese GAAP] (Consolidated)
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜2229＞ Calbee 3147 3386 3202 ＜2301＞ Academic Information 1790 1795 1795.5 ＜2445＞ Takamiya 539 572 540.5 ＜3393＞
Daiwa House, Meiji HD, Shiseido, Sumitomo Electric (10th) (1301-5998)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/10 (Fri) ＜1301＞Kyokuyo ＜1379＞Hokuto ＜1414＞Show Bond ＜1420＞Sanyo H＜1429＞Japan Aqua ＜1431＞Ribwork＜1435＞Robot Home ＜1438＞Gifu Landscaping＜1
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○ List of buy conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2301＞ academic information 1839 1682 ＜2326＞ Digiarts 4425 4040 ＜2379＞ dip 2770 2576 ＜2440＞ GURUNAVI 335 295 ＜2461＞ fan reviews
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Prior Span B Tokyo Stock Exchange Prime ＜3031＞ Raccoon HD 653 621.75 651 ＜7380＞ 16 FG 4560 4546.25 4280 ＜7581＞ Saizeriya 5280 4937.5 5212.5 ＜9692＞ CEC 1717 170
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1873＞ Japan House HD 337 361 ＜2882＞ Eat and 1983 2046 ＜3288＞ Open H 4919 5054 ＜3387＞ Kriles HD 1045 1070 ＜3501＞ Suminoe Textile
Taiko Pharmaceutical Raises FY Net View to Y550.00M
GROUP New Forecast Prior For Year To Dec 2024 Forecast Revenue Y6.80 bln Y6.80 bln Operating Profit Y410.00 mln
Taiko Pharmaceutical Sees FY Net Y350.00M
Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2024 Revenue Y6.80 bln Operating Profit Y410.00 mln Pre
Taiko Pharmaceutical 9-Mos Loss Y562.00M Vs Loss Y3.18B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Nine Months Ended September 30 GROUP 2023 2022 Revenue Y4.42 bln Y3.39 bln Operating Profit
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical
Kingworld Medicines Group (HKG:1110) subsidiary Kingworld Medicines Health Management purchased an additional 1,007,500 shares in Japan-based Taiko Pharmaceutical (TYO:4574) at 338.58 yen per share, a
Jinhuo Pharmaceutical Group (01110.HK): Further subscription for shares in Taiko Pharmaceutical
On August 16, 2023, Goldwell Pharmaceutical Group (01110.HK) issued an announcement. On August 15, 2023, Jinhuo Pharmaceutical, a wholly-owned subsidiary of the company, placed an order with the distribution agent. Based on this, Jinhuo Pharmaceutical agreed to subscribe for an additional 1.075 million Taiko shares at a cost of 338.58 yen (equivalent to about HK$18.35) per share of Taiko Shares (accounting for about 2.08% of Taiko Pharmaceutical's issued share capital as of the date of this announcement, excluding Taiko Pharmaceutical After completion, according to the subscription details
Analysis
Price Target
No Data
